{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:47:46Z","timestamp":1787510866714,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003032","name":"Association Nationale de la Recherche et de la Technologie","doi-asserted-by":"publisher","award":["2021\/1440"],"award-info":[{"award-number":["2021\/1440"]}],"id":[{"id":"10.13039\/501100003032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-PESN-0017"],"award-info":[{"award-number":["ANR-22-PESN-0017"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022107","name":"Universit\u00e9 de Limoges","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022107","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40262-025-01526-z","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T03:58:46Z","timestamp":1748059126000},"page":"1061-1069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetic\/Pharmacodynamic Modelling and Monte Carlo Simulations to Predict Cytomegalovirus Viral Load in Pediatric Transplant Recipients Treated with (val)Ganciclovir"],"prefix":"10.1007","volume":"64","author":[{"given":"K\u00e9vin","family":"Koloskoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Franck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Autmizguine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Theoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Briand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ovetchkine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-0695","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Woillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"8","key":"1526_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1086\/339329","volume":"34","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34(8):1094\u20137.","journal-title":"Clin Infect Dis"},{"key":"1526_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102:900\u201331.","journal-title":"Transplantation"},{"key":"1526_CR3","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","volume":"44","author":"MD Pescovitz","year":"2000","unstructured":"Pescovitz MD, Rabkin J, Merion RM, Paya CV, Pirsch J, Freeman RB, et al. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother. 2000;44:2811\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1526_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1086\/319225","volume":"32","author":"N Singh","year":"2001","unstructured":"Singh N. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis. 2001;32:742\u201351.","journal-title":"Clin Infect Dis"},{"key":"1526_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cpt.2431","volume":"112","author":"B Franck","year":"2022","unstructured":"Franck B, Autmizguine J, Marquet P, Ovetchkine P, Woillard J-B. Pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring of valganciclovir and ganciclovir in transplantation. Clin Pharmacol Ther. 2022;112:233\u201376.","journal-title":"Clin Pharmacol Ther"},{"key":"1526_CR6","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1111\/bcp.14719","volume":"87","author":"B Franck","year":"2021","unstructured":"Franck B, Woillard J-B, Th\u00e9or\u00eat Y, Bittencourt H, Demers E, Briand A, et al. Population pharmacokinetics of ganciclovir and valganciclovir in paediatric solid organ and stem cell transplant recipients. Br J Clin Pharmacol. 2021;87:3105\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"1526_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/14787210.2021.1851193","volume":"19","author":"SA Ho","year":"2021","unstructured":"Ho SA, Slavin M, Roberts JA, Yong M. Optimization of ganciclovir use in allogeneic hematopoietic cell transplant recipients - the role of therapeutic drug monitoring. Expert Rev Anti Infect Ther. 2021;19:707\u201318.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1526_CR8","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/jac\/dkab195","volume":"76","author":"A-G M\u00e4rtson","year":"2021","unstructured":"M\u00e4rtson A-G, Edwina AE, Burgerhof JGM, Berger SP, de Joode A, Damman K, et al. Ganciclovir therapeutic drug monitoring in transplant recipients. J Antimicrob Chemother. 2021;76:2356\u201363.","journal-title":"J Antimicrob Chemother"},{"key":"1526_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/FTD.0000000000000925","volume":"44","author":"A-G M\u00e4rtson","year":"2022","unstructured":"M\u00e4rtson A-G, Edwina AE, Kim HY, Knoester M, Touw DJ, Sturkenboom MGG, et al. Therapeutic drug monitoring of ganciclovir: where are we? Ther Drug Monit. 2022;44:138\u201347.","journal-title":"Ther Drug Monit"},{"key":"1526_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40262-020-00982-z","volume":"60","author":"PR Selby","year":"2021","unstructured":"Selby PR, Shakib S, Peake SL, Warner MS, Yeung D, Hahn U, et al. A systematic review of the clinical pharmacokinetics, pharmacodynamics and toxicodynamics of ganciclovir\/valganciclovir in allogeneic haematopoietic stem cell transplant patients. Clin Pharmacokinet. 2021;60:727\u201339.","journal-title":"Clin Pharmacokinet"},{"key":"1526_CR11","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/01.TP.0000164512.99703.AD","volume":"79","author":"H Wiltshire","year":"2005","unstructured":"Wiltshire H, Paya CV, Pescovitz MD, Humar A, Dominguez E, Washburn K, et al. Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients. Transplantation. 2005;79:1477\u201383.","journal-title":"Transplantation"},{"key":"1526_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1517\/17425255.2015.988139","volume":"11","author":"C Stockmann","year":"2015","unstructured":"Stockmann C, Roberts JK, Knackstedt ED, Spigarelli MG, Sherwin CM. Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection. Expert Opin Drug Metab Toxicol. 2015;11:205\u201319.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1526_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s40262-021-01034-w","volume":"60","author":"B Franck","year":"2021","unstructured":"Franck B, Autmizguine J, \u00c5sberg A, Th\u00e9or\u00eat Y, Marquet P, Ovetchkine P, et al. Thoroughly validated Bayesian estimator and limited sampling strategy for dose individualization of ganciclovir and valganciclovir in pediatric transplant recipients. Clin Pharmacokinet. 2021;60:1449\u201362.","journal-title":"Clin Pharmacokinet"},{"key":"1526_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/FTD.0b013e3182509e3a","volume":"34","author":"W Zhao","year":"2012","unstructured":"Zhao W, Fakhoury M, Fila M, Baudouin V, Desch\u00eanes G, Jacqz-Aigrain E. Individualization of valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant patients. Ther Drug Monit. 2012;34:326\u201330.","journal-title":"Ther Drug Monit"},{"key":"1526_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jchromb.2008.01.046","volume":"864","author":"M Kasiari","year":"2008","unstructured":"Kasiari M, Gikas E, Georgakakou S, Kazanis M, Panderi I. Selective and rapid liquid chromatography\/negative-ion electrospray ionization mass spectrometry method for the quantification of valacyclovir and its metabolite in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;864:78\u201386.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1526_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/00003088-200140050-00004","volume":"40","author":"J Debord","year":"2001","unstructured":"Debord J, Risco E, Harel M, Le Meur Y, B\u00fcchler M, Lach\u00e2tre G, et al. Application of a gamma model of absorption to oral cyclosporin. Clin Pharmacokinet. 2001;40:375\u201382.","journal-title":"Clin Pharmacokinet"},{"key":"1526_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","volume":"11","author":"M Bergstrand","year":"2009","unstructured":"Bergstrand M, Karlsson MO. Handling data below the limit of quantification in mixed effect models. AAPS J. 2009;11:371\u201380.","journal-title":"AAPS J"},{"key":"1526_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01665-22","volume":"67","author":"PG Cojutti","year":"2023","unstructured":"Cojutti PG, Heffernan AJ, T\u00e4ngd\u00e9n T, Della Siega P, Tascini C, Roberts JA, et al. Population pharmacokinetic and pharmacodynamic analysis of valganciclovir for optimizing preemptive therapy of cytomegalovirus infections in kidney transplant recipients. Antimicrob Agents Chemother. 2023;67: e0166522.","journal-title":"Antimicrob Agents Chemother"},{"key":"1526_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33: e13512.","journal-title":"Clin Transplant"},{"key":"1526_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/jac\/dkab419","volume":"77","author":"A-G M\u00e4rtson","year":"2022","unstructured":"M\u00e4rtson A-G, Sturkenboom MGG, Knoester M, van der Werf TS, Alffenaar JWC, Hope W, et al. Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads. J Antimicrob Chemother. 2022;77:466\u201373.","journal-title":"J Antimicrob Chemother"},{"issue":"e133960","key":"1526_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133960","volume":"131","author":"ER Duke","year":"2021","unstructured":"Duke ER, Williamson BD, Borate B, Golob JL, Wychera C, Stevens-Ayers T, et al. CMV viral load kinetics as surrogate endpoints after allogeneic transplantation. J Clin Invest. 2021;131(e133960): 133960.","journal-title":"J Clin Invest"},{"key":"1526_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.coph.2008.06.010","volume":"8","author":"S Schmidt","year":"2008","unstructured":"Schmidt S, Barbour A, Sahre M, Rand KH, Derendorf H. PK\/PD: new insights for antibacterial and antiviral applications. Curr Opin Pharmacol. 2008;8:549\u201356.","journal-title":"Curr Opin Pharmacol"},{"key":"1526_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.antiviral.2019.01.008","volume":"163","author":"RF Chemaly","year":"2019","unstructured":"Chemaly RF, Hill JA, Voigt S, Peggs KS. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: a systematic literature review. Antiviral Res. 2019;163:50\u20138.","journal-title":"Antiviral Res"},{"key":"1526_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","volume":"9","author":"A Asberg","year":"2009","unstructured":"Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, et al. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant. 2009;9:1205\u201313.","journal-title":"Am J Transplant"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01526-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T10:56:39Z","timestamp":1750676199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01526-z","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"6 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e9 de Limoges. K\u00e9vin Koloskoff received funding from the \u201cassociation nationale recherche technologie\u201d through a \u201cconvention industrielle de formation par la recherche\u201d thesis (n\u00b02021\/1440). This research was also supported by ExactCure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Supporting information is available in the ESM files, and supporting data and the Mlxtran model code are available from the authors on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol was approved by the institutional review board of CHU Sainte-Justine (reference number 2018-1830). Data were completely deidentified in accordance with the European General Data Protection Regulation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KK wrote the manuscript. KK, JBW, and SB designed the research. All authors performed the research. KK, BF, JA, PO, and JBW analyzed the data.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors contributions"}}]}}